查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943289

氣喘預警感測器市場 - 全球產業規模、佔有率、趨勢、機會及預測（按類型、技術、測量參數、最終用戶、地區和競爭格局分類，2021-2031年）

Asthma Warning Sensors Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Type, By Technology, By Parameter Measured, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球氣喘預警感測器市場預計將從 2025 年的 125.5 億美元成長到 2031 年的 219.2 億美元，年複合成長率為 9.74%。

這些電子監測系統旨在檢測環境因素和生理變化，並在氣喘即將發作時向使用者發出警報。推動這一成長的關鍵因素包括全球慢性呼吸系統疾病發病率的上升，以及遠端患者監護工具與醫療保健基礎設施的深度整合。此外，都市區日益嚴重的空氣污染也促使人們需要能夠幫助主動管理病情並最大限度減少緊急就醫的個人健康設備。

市場概覽
預測期 2027-2031
市場規模：2025年 125.5億美元
市場規模：2031年 219.2億美元
複合年成長率：2026-2031年 9.74%
成長最快的細分市場 穿戴式裝置
最大的市場 北美洲

然而，醫療設備市場面臨許多重大障礙，例如嚴格的監管合規標準，這些標準延長了產品開發週期，並增加了生產商和最終用戶的成本。這種監管負擔常常阻礙創新技術在最需要的地區的應用。近期的數據凸顯了這些健康和環境監測解決方案的迫切性：根據美國肺臟協會2024年的報告，美國有1.312億人居住在空氣污染嚴重的地區。

市場促進因素

全球氣喘和呼吸系統疾病發生率的不斷上升是推動氣喘預警感測器廣泛應用的主要因素。國際診斷率的上升迫使醫療衛生系統實施有效的管理策略，以避免嚴重氣喘發作和住院治療，從而推動了對具備早期預警功能的連續監測設備的需求。例如，世界衛生組織（WHO）在2024年5月指出，全球約有2.62億人患有氣喘，顯示此類技術擁有龐大的市場。此外，未治療氣喘帶來的巨大經濟負擔也促使人們尋求經濟有效的解決方案。美國氣喘和過敏基金會（AAFA）在2024年3月報告稱，美國每年因氣喘造成的經濟損失超過820億美元，凸顯了對先進預防工具的迫切需求。

物聯網整合和穿戴式感測器技術的快速發展正在重塑市場格局，提升設備效能並提高用戶依從性。現代感測器通常能夠即時追蹤藥物使用情況，並與行動應用程式無縫同步，使患者和臨床醫生能夠監測環境因素和治療效果。這些技術進步支持遠端監測，並透過促進嚴格的用藥依從性和實現及時護理，顯著改善了臨床療效。 2024 年發表在《氣喘雜誌》（Journal of Asthma）上的一項研究發現，使用智慧吸入器技術的重度氣喘患者的症狀控制顯著改善，其氣喘控制調查問卷（ACQ-6）評分從基準的 2.81 分降至隨訪時的 1.92 分。這項已證實的效用正在加速將連網設備納入標準呼吸系統疾病通訊協定。

市場挑戰

嚴格的監管合規性對全球氣喘預警感測器市場的成長構成重大障礙。由於這些設備越來越依賴臨床級監測和預測演算法，它們通常被歸類為醫療設備而非普通家用電子電器產品，並須接受全球衛生機構嚴格的安全檢驗、測試和資料隱私要求。管理這些複雜的核准流程需要耗費大量資源，迫使製造商延長研發週期，最終延緩尖端感測技術的商業性化應用。因此，這些高准入門檻阻礙了小規模創新者的進入，並減緩了整個產業的技術進步速度。

這些監管要求帶來的營運和財務壓力巨大且可衡量。製造商被迫投入大量資金用於認證和合規，擠佔了原本可用於研發的資金，使得推出新型感測器的成本高得令人望而卻步。據歐洲醫療技術協會（MedTech Europe）稱，到2024年，醫療設備認證和維護成本將比上一指令增加高達100%，導致33%的領先製造商放棄選擇該地區作為其首款產品上市地。這些成本的增加和由此造成的延誤限制了患者獲得氣喘管理所需工具的機會，並阻礙了市場對日益惡化的環境因素做出快速反應的能力。

市場趨勢

人工智慧驅動的預測分析技術的整合正在將全球氣喘預警感測器市場從被動的警報系統轉變為主動的預測工具。透過分析環境因素和電子健康記錄等複雜資料來源，先進的演算法可以在出現身體症狀之前很久就檢測到氣喘發作風險。這種轉變使醫療服務提供者能夠早期療育，避免嚴重氣喘發作，從而最佳化醫療系統資源。近期研究也證實了這些模型的臨床有效性。根據2025年5月發表在《EClinicalMedicine》雜誌上的一項研究，一種基於人工智慧的新型被動式數位標記的曲線下面積（AUC）達到了0.79，這一預測準確性指標顯著優於傳統的風險評估方法。

同時，基於智慧型手機的聲學喘鳴分析技術的興起，使得無需專用設備，僅需使用標準行動麥克風即可進行客觀評估，從而拓展了市場。該技術透過評估呼吸音和音頻生物標記來識別氣道阻塞，為患者提供了一種便捷、非侵入性的替代峰值流量計和肺功能儀的檢測方法。使用常見的家用電子電器即可進行臨床層級的評估，降低了先進監測解決方案的進入門檻。這些聲學診斷工具的診斷準確性得到了可靠數據的支持。 2025年3月發表在《醫療保健》（Healthcare）雜誌上的一項研究報告稱，一種分析特定音頻音素的機器學習模型在判斷氣喘狀態方面達到了98.7%的分類準確率。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

5. 全球氣喘預警感測器市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（穿戴式/不穿戴式）
    • 按技術（人工智慧、物聯網、機器學習等）
    • 透過測量參數（FEV1 與峰值流速）
    • 按最終用戶分類（醫院/診所 vs.居家醫療）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美氣喘預警感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲氣喘預警感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區氣喘預警感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲氣喘預警感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲氣喘預警感測器市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球氣喘預警感測器市場：SWOT分析

第14章 波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Philips Healthcare
  • ResMed Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Propeller Health
  • Adherium Limited
  • Cohero Health, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 9317

The Global Asthma Warning Sensors Market is projected to expand from USD 12.55 Billion in 2025 to USD 21.92 Billion by 2031, reflecting a compound annual growth rate of 9.74%. These electronic monitoring systems are engineered to identify environmental triggers or physiological shifts, thereby alerting users to impending asthma attacks. Key factors propelling this growth include the rising worldwide incidence of chronic respiratory conditions and the deeper integration of remote patient monitoring tools into healthcare infrastructures. Furthermore, worsening air pollution in urban areas is fueling the need for personal health devices that support proactive management and help minimize emergency hospital visits.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 12.55 Billion
Market Size 2031USD 21.92 Billion
CAGR 2026-20319.74%
Fastest Growing SegmentWearable
Largest MarketNorth America

However, the market faces a substantial hurdle in the form of rigorous regulatory compliance standards for medical devices, which extends product development timelines and inflates costs for both producers and end-users. This regulatory burden frequently postpones the arrival of innovative technologies in regions where they are most critically needed. The urgency for these health and environmental monitoring solutions is underscored by recent data; according to the American Lung Association's 2024 report, 131.2 million individuals in the United States resided in locations plagued by unhealthy air pollution levels.

Market Driver

The escalating global incidence of asthma and respiratory disorders acts as a major driver for the broad adoption of asthma warning sensors. As diagnosis rates climb internationally, health systems are under mounting pressure to deploy effective management strategies that avert severe flare-ups and hospital stays, leading to higher demand for continuous monitoring devices with early warning features. For example, the World Health Organization highlighted in May 2024 that asthma impacts roughly 262 million individuals globally, establishing a massive market for these technologies. Additionally, the significant financial strain of untreated conditions drives the need for cost-efficient solutions; the Asthma and Allergy Foundation of America reported in March 2024 that asthma's annual economic cost to the U.S. surpassed $82 billion, highlighting the financial necessity for advanced preventive tools.

Rapid progress in IoT integration and wearable sensor technology is reshaping the market by upgrading device capabilities and boosting user adherence. Contemporary sensors now frequently track medication use in real-time and synchronize seamlessly with mobile apps, enabling patients and clinicians to monitor environmental triggers and treatment success. These technical enhancements support remote monitoring and significantly better clinical results by promoting strict medication adherence and facilitating prompt care. A 2024 study in the Journal of Asthma revealed that severe asthma patients using smart inhaler technology saw marked improvements in control, with Asthma Control Questionnaire (ACQ-6) scores dropping from a baseline of 2.81 to 1.92 at follow-up, a proven utility that accelerates the adoption of connected devices in standard respiratory protocols.

Market Challenge

Rigorous regulatory compliance represents a significant obstacle to the growth of the Global Asthma Warning Sensors Market. Because these devices increasingly rely on clinical-grade monitoring and predictive algorithms, they are often categorized as medical devices rather than standard consumer electronics, subjecting them to stringent safety validation, testing, and data privacy mandates from global health authorities. The substantial resources needed to manage these complicated approval processes force manufacturers to extend development timelines, effectively delaying the commercial release of cutting-edge sensing technologies. Consequently, these high entry barriers deter smaller innovators and reduce the overall speed of technological progress within the industry.

The operational and financial pressure caused by these regulatory requirements is both severe and measurable. Manufacturers are compelled to direct substantial capital toward certification and compliance, diverting funds that could otherwise support research and development, making the cost of launching new sensors prohibitive. According to MedTech Europe, certification and maintenance expenses for medical devices rose by up to 100% in 2024 compared to earlier directives, resulting in a 33% reduction in major manufacturers choosing the region for initial product launches. These increased costs and subsequent delays restrict patient access to essential asthma management tools and hinder the market's capacity to react quickly to worsening environmental factors.

Market Trends

The integration of AI-powered predictive analytics is transforming the Global Asthma Warning Sensors Market from reactive alerting systems into proactive forecasting tools. By analyzing complex data sources like environmental variables and electronic health records, advanced algorithms can detect the risk of exacerbations well before physical symptoms manifest. This shift enables healthcare providers to execute early interventions that avert severe attacks, thereby optimizing health system resource usage. Recent research validates the clinical power of these models; a May 2025 study in EClinicalMedicine noted that a new AI-based passive digital marker achieved a prognostic accuracy Area Under the Curve (AUC) of 0.79, significantly surpassing traditional risk assessment methods.

Concurrently, the rise of smartphone-based acoustic wheeze analysis is broadening market reach by using standard mobile microphones for objective assessment, removing the need for dedicated hardware. This technology evaluates respiratory sounds and vocal biomarkers to identify airway obstruction, providing patients with a convenient, non-invasive substitute for peak flow meters or spirometry. The capacity to conduct clinical-grade assessments via common consumer electronics lowers entry barriers for sophisticated monitoring solutions. The diagnostic strength of these acoustic tools is backed by robust data; a study published in Healthcare in March 2025 reported that a machine learning model analyzing specific speech phonemes achieved a classification accuracy of 98.7% in determining asthma status.

Key Market Players

  • Philips Healthcare
  • ResMed Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Propeller Health
  • Adherium Limited
  • Cohero Health, Inc.

Report Scope

In this report, the Global Asthma Warning Sensors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Asthma Warning Sensors Market, By Type

  • Wearable v/s Non-Wearable

Asthma Warning Sensors Market, By Technology

  • AI
  • IoT
  • Machine Learning
  • Others

Asthma Warning Sensors Market, By Parameter Measured

  • FEV1 v/s Peak Flow

Asthma Warning Sensors Market, By End User

  • Hospitals & Clinics v/s Homecare

Asthma Warning Sensors Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Asthma Warning Sensors Market.

Available Customizations:

Global Asthma Warning Sensors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Asthma Warning Sensors Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Wearable v/s Non-Wearable)
    • 5.2.2. By Technology (AI, IoT, Machine Learning, Others)
    • 5.2.3. By Parameter Measured (FEV1 v/s Peak Flow)
    • 5.2.4. By End User (Hospitals & Clinics v/s Homecare)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Asthma Warning Sensors Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Technology
    • 6.2.3. By Parameter Measured
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Asthma Warning Sensors Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Parameter Measured
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Asthma Warning Sensors Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Parameter Measured
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Asthma Warning Sensors Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Parameter Measured
        • 6.3.3.2.4. By End User

7. Europe Asthma Warning Sensors Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Technology
    • 7.2.3. By Parameter Measured
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Asthma Warning Sensors Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Parameter Measured
        • 7.3.1.2.4. By End User
    • 7.3.2. France Asthma Warning Sensors Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Parameter Measured
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Asthma Warning Sensors Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Parameter Measured
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Asthma Warning Sensors Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Parameter Measured
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Asthma Warning Sensors Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Parameter Measured
        • 7.3.5.2.4. By End User

8. Asia Pacific Asthma Warning Sensors Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Technology
    • 8.2.3. By Parameter Measured
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Asthma Warning Sensors Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Parameter Measured
        • 8.3.1.2.4. By End User
    • 8.3.2. India Asthma Warning Sensors Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Parameter Measured
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Asthma Warning Sensors Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Parameter Measured
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Asthma Warning Sensors Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Parameter Measured
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Asthma Warning Sensors Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Parameter Measured
        • 8.3.5.2.4. By End User

9. Middle East & Africa Asthma Warning Sensors Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Technology
    • 9.2.3. By Parameter Measured
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Asthma Warning Sensors Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Parameter Measured
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Asthma Warning Sensors Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Parameter Measured
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Asthma Warning Sensors Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Parameter Measured
        • 9.3.3.2.4. By End User

10. South America Asthma Warning Sensors Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Technology
    • 10.2.3. By Parameter Measured
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Asthma Warning Sensors Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Parameter Measured
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Asthma Warning Sensors Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Parameter Measured
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Asthma Warning Sensors Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Parameter Measured
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Asthma Warning Sensors Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Philips Healthcare
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. ResMed Inc.
  • 15.3. Teva Pharmaceutical Industries Ltd.
  • 15.4. GlaxoSmithKline plc
  • 15.5. Novartis AG
  • 15.6. AstraZeneca plc
  • 15.7. Merck & Co., Inc.
  • 15.8. Propeller Health
  • 15.9. Adherium Limited
  • 15.10. Cohero Health, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer